Logo image of PCN

PIMCO CORPORATE & INCOME STR (PCN) Stock Price, Quote, News and Overview

NYSE:PCN - New York Stock Exchange, Inc. - US72200U1007 - Currency: USD

12.64  +0.01 (+0.08%)

Fundamental Rating

2

Taking everything into account, PCN scores 2 out of 10 in our fundamental rating. PCN was compared to 0 industry peers in the Unkown industry. Both the profitability and financial health of PCN have multiple concerns. PCN is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

PCN had positive earnings in the past year.
PCN had a positive operating cash flow in the past year.
Of the past 5 years PCN 4 years were profitable.
In multiple years PCN reported negative operating cash flow during the last 5 years.
PCN Yearly Net Income VS EBIT VS OCF VS FCFPCN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M -200M

1.2 Ratios

Industry RankSector Rank
ROA 9.47%
ROE 11.56%
ROIC 5.68%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
PCN Yearly ROA, ROE, ROICPCN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 15

1.3 Margins

PCN's Profit Margin has improved in the last couple of years.
In the last couple of years the Operating Margin of PCN has remained more or less at the same level.
PCN's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 80.6%
PM (TTM) 107.46%
GM 79.1%
OM growth 3Y-2.08%
OM growth 5Y-1.16%
PM growth 3YN/A
PM growth 5Y10.3%
GM growth 3Y-2.8%
GM growth 5Y-1.61%
PCN Yearly Profit, Operating, Gross MarginsPCN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 100 150 200

More info and screens

2

2. Health

2.1 Basic Checks

There is no outstanding debt for PCN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
PCN Yearly Shares OutstandingPCN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M
PCN Yearly Total Debt VS Total AssetsPCN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M 800M 1B

2.2 Solvency

PCN has an Altman-Z score of 3.40. This indicates that PCN is financially healthy and has little risk of bankruptcy at the moment.
The Debt to FCF ratio of PCN is 2.90, which is a good value as it means it would take PCN, 2.90 years of fcf income to pay off all of its debts.
A Debt/Equity ratio of 0.20 indicates that PCN is not too dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.2
Debt/FCF 2.9
Altman-Z 3.4
ROIC/WACCN/A
WACCN/A
PCN Yearly LT Debt VS Equity VS FCFPCN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M 600M

2.3 Liquidity

A Current Ratio of 0.16 indicates that PCN may have some problems paying its short term obligations.
A Quick Ratio of 0.16 indicates that PCN may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0.16
Quick Ratio 0.16
PCN Yearly Current Assets VS Current LiabilitesPCN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M

More info and screens

2

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 51.15% over the past year.
The Earnings Per Share has been growing slightly by 6.15% on average over the past years.
Looking at the last year, PCN shows a decrease in Revenue. The Revenue has decreased by -2.13% in the last year.
PCN shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.95% yearly.
EPS 1Y (TTM)51.15%
EPS 3YN/A
EPS 5Y6.15%
EPS Q2Q%-2.02%
Revenue 1Y (TTM)-2.13%
Revenue growth 3Y3.31%
Revenue growth 5Y3.95%
Sales Q2Q%34.19%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
PCN Yearly Revenue VS EstimatesPCN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 10.19, the valuation of PCN can be described as reasonable.
Compared to an average S&P500 Price/Earnings ratio of 26.82, PCN is valued rather cheaply.
Industry RankSector Rank
PE 10.19
Fwd PE N/A
PCN Price Earnings VS Forward Price EarningsPCN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF 19.25
EV/EBITDA N/A
PCN Per share dataPCN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)1.66
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 10.68%, PCN is a good candidate for dividend investing.
PCN's Dividend Yield is rather good when compared to the S&P500 average which is at 2.39.
Industry RankSector Rank
Dividend Yield 10.68%

5.2 History

PCN has paid a dividend for at least 10 years, which is a reliable track record.
PCN has decreased its dividend recently.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years1
PCN Yearly Dividends per sharePCN Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1

5.3 Sustainability

PCN pays out 95.83% of its income as dividend. This is not a sustainable payout ratio.
DP95.83%
EPS Next 2YN/A
EPS Next 3YN/A
PCN Yearly Income VS Free CF VS DividendPCN Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M -200M
PCN Dividend Payout.PCN Dividend Payout, showing the Payout Ratio.PCN Dividend Payout.PayoutRetained Earnings

More info and screens

PIMCO CORPORATE & INCOME STR

NYSE:PCN (8/1/2025, 8:04:00 PM)

12.64

+0.01 (+0.08%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)03-03 2025-03-03
Earnings (Next)09-22 2025-09-22
Inst Owners15.9%
Inst Owner Change1.2%
Ins OwnersN/A
Ins Owner Change0%
Market Cap808.71M
Analysts0
Price TargetN/A
Short Float %0.17%
Short Ratio0.43
Dividend
Industry RankSector Rank
Dividend Yield 10.68%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP95.83%
Div Incr Years0
Div Non Decr Years1
Ex-Date07-11 2025-07-11 (0.1125)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 10.19
Fwd PE N/A
P/S 12.07
P/FCF 19.25
P/OCF 19.25
P/B 1.3
P/tB 1.3
EV/EBITDA N/A
EPS(TTM)1.24
EY9.81%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.66
FCFY5.19%
OCF(TTM)0.66
OCFY5.19%
SpS1.05
BVpS9.74
TBVpS9.74
PEG (NY)N/A
PEG (5Y)1.66
Profitability
Industry RankSector Rank
ROA 9.47%
ROE 11.56%
ROCE 8.58%
ROIC 5.68%
ROICexc 5.68%
ROICexgc 5.85%
OM 80.6%
PM (TTM) 107.46%
GM 79.1%
FCFM 62.69%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-2.08%
OM growth 5Y-1.16%
PM growth 3YN/A
PM growth 5Y10.3%
GM growth 3Y-2.8%
GM growth 5Y-1.61%
F-Score4
Asset Turnover0.09
Health
Industry RankSector Rank
Debt/Equity 0.2
Debt/FCF 2.9
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 250
Cash Conversion N/A
Profit Quality 58.33%
Current Ratio 0.16
Quick Ratio 0.16
Altman-Z 3.4
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)51.15%
EPS 3YN/A
EPS 5Y6.15%
EPS Q2Q%-2.02%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-2.13%
Revenue growth 3Y3.31%
Revenue growth 5Y3.95%
Sales Q2Q%34.19%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-2.92%
EBIT growth 3Y1.16%
EBIT growth 5Y2.74%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-106.91%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y117.78%
OCF growth 3YN/A
OCF growth 5YN/A